RO87008B1 - Anaemia preventing medicament - Google Patents

Anaemia preventing medicament

Info

Publication number
RO87008B1
RO87008B1 RO110708A RO11070883A RO87008B1 RO 87008 B1 RO87008 B1 RO 87008B1 RO 110708 A RO110708 A RO 110708A RO 11070883 A RO11070883 A RO 11070883A RO 87008 B1 RO87008 B1 RO 87008B1
Authority
RO
Romania
Prior art keywords
iron
rotacyl
drug
anaemia
ascorbic
Prior art date
Application number
RO110708A
Other languages
Romanian (ro)
Inventor
Nicolae Oita
Mihai Lazar
Minodor Cojocaru
Original Assignee
Nicolae Oita
Mihai Lazar
Minodor Cojocaru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicolae Oita, Mihai Lazar, Minodor Cojocaru filed Critical Nicolae Oita
Priority to RO110708A priority Critical patent/RO87008B1/en
Publication of RO87008B1 publication Critical patent/RO87008B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Medicamentul, conform inventiei, contine ca sursa de fier lacatul de fier care în asociere cu acetilrutosidul (rutacilul) si acidul ascorbic, realizeaza în mediul apos un fier bivalent chelat stabilizat de sistemul redox rutacil-acid ascorbic. Medicamentul este activ în tratamentul anemiilor feriprive, iar refacerea hematiilor se realizeaza într-un timp mai scurt decît cu alte forme de fier. Existenta în compozitie a unui factor de permeabilitate, rutacitul face ca rezistenta globulara a hematiei sa se îmbunatateasca foarte mult. Medicamentul este bine tolerat digestiv.According to the invention, the iron-containing iron source, which in combination with acetylrutoside (rotacyl) and ascorbic acid, produces in the aqueous medium a chelated bivalent iron stabilized by the rotacyl-ascorbic redox system. The drug is active in the treatment of iron-deficiency anemias, and the recovery of the red blood cells occurs in a shorter time than other forms of iron. The existence of a permeability factor in the composition, rotation, makes the globular resistance of the hematite greatly improved. The drug is well digested.

RO110708A 1983-04-20 1983-04-20 Anaemia preventing medicament RO87008B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO110708A RO87008B1 (en) 1983-04-20 1983-04-20 Anaemia preventing medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO110708A RO87008B1 (en) 1983-04-20 1983-04-20 Anaemia preventing medicament

Publications (1)

Publication Number Publication Date
RO87008B1 true RO87008B1 (en) 1985-05-31

Family

ID=40903787

Family Applications (1)

Application Number Title Priority Date Filing Date
RO110708A RO87008B1 (en) 1983-04-20 1983-04-20 Anaemia preventing medicament

Country Status (1)

Country Link
RO (1) RO87008B1 (en)

Similar Documents

Publication Publication Date Title
Pitts Some reflections on mechanisms of action of diuretics
CA2263379A1 (en) Method for iron delivery to a patient by transfer from dialysate
GB1470428A (en) Blood dialysis apparatus
ATE108771T1 (en) CHELATING AGENTS FOR THE COMPLEXATION OF RADIOACTIVE ISOTOPES, THEIR METAL COMPLEXES AND THEIR USE IN DIAGNOSTICS AND THERAPY.
Perry Jr et al. Hypertension and tissue metal levels after intraperitoneal cadmium, mercury, and zinc
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
FI965145A0 (en) filtration
MY130555A (en) Super absorbent polymer composition
ATE259644T1 (en) TREATMENT OF ERYTHROCYTES CONTAINING HEMOGLOBIN WITH NITROGEN OXIDE
PL334437A1 (en) Pharmaceutical compositions for use in haemodialysis and pertitoneal dialysis as well as method of performing the both dialysis type using such compositions
GB1438919A (en) Compositions comprising chelated radioactive heave metals
RO87008B1 (en) Anaemia preventing medicament
JPS57134419A (en) Stable anticoagulant of blood
GB8507897D0 (en) Pyridine derivatives
FR2607702B1 (en) READY-TO-USE INJECTABLE SOLUTIONS CONTAINING AN ANTI-TUMOR AGENT OF THE ANTHRACYCLINE-GLUCOSIDE TYPE
Vorobieva et al. Cardiovascular function in workers exposed to cadmium
JPS56150017A (en) Cholesteril lowering agent
Hamer et al. Adverse effects of lisinopril.
SU1063392A1 (en) Method of excretory urography
Dressler On the Nature and Mechanism of Action of the Copper-protein Tyrosinase
IT8504854A0 (en) CLOTHING, IN PARTICULAR DIAPER, TO BE THROWN AWAY.
Bronisch et al. Investigations on effects of experimental lead-intoxication.
NODA Selective Angiography Subclavian Steal Syndrome
GB1128023A (en) Process for preparing sulphuric acid esters of levans
Nordenstam Flora conservation projects in Sweden.).